[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354120-105":59,"doc-detail-354120-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-tnbc-core-shell-polycationic-polyureadendrimers-with-inherent-anticancer-activity","Targeting TNBC - core-shell polycationic polyureadendrimers with inherent anticancer activity","","Targeting triple-negative breast cancer (TNBC) with precision nanostructures, the study assesses two novel core–shell polycationic polyurea (PURE) dendrimers, PUREG4-OEI48 and PUREG4-OCEI24, designed to bind negatively charged cancer cell membranes. Both dendrimers selectively interact with TNBC cells and trigger apoptosis, necroptosis, and ferroptosis. In HCC1806 xenograft models, they reduce tumor volume; PUREG4-OEI48 shows no toxicity, whereas PUREG4-OCEI24 causes mild hepatic toxicity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-tnbc-core-shell-polycationic-polyureadendrimers-with-inherent-anticancer-activity/354120/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-tnbc-core-shell-polycationic-polyureadendrimers-with-inherent-anticancer-activity/354120.png","ImageObject",300,407,{"name":92,"@type":93},"Aditya","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What TNBC problem does this research target?","Question",{"text":112,"@type":113},"The research addresses limited targeted therapy options for TNBC and the poor survival associated with late diagnosis and metastasis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which two PURE dendrimers are investigated?",{"text":117,"@type":113},"The study evaluates PUREG4-OEI48 and PUREG4-OCEI24, both designed as core–shell polycationic polyurea dendrimers for TNBC membrane targeting.",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes are observed in vitro and in vivo?",{"text":121,"@type":113},"In TNBC cells, the dendrimers induce apoptosis, necroptosis, and ferroptosis; in HCC1806 xenografts, they reduce tumor volume, with PUREG4-OEI48 showing no toxicity and PUREG4-OCEI24 causing mild hepatic toxicity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354120,1790226966,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","RESEARCH ARTICLE  \nTargeting TNBC: core–shell polycationic polyureadendrimers with inherent anticancer activity  \nAdriana Cruz 1, Bruna Abreu2,3, Cindy Mendes2,3, Catarina Freitas-Dias2,3, Filipe Gonalves3, Fernanda Silva2, Jos´e Ramalho2, Saudade Andr´e2,3, Vasco D. B. Bonif´acio 1,4 and  \nJacinta Serpa2,3   \n1 iBB-Institute for Bioengineering and Biosciences, and Associate Laboratory i4HB-Institute for Health and Bioeconomy, Instituto Superior T´ecnico, Lisbon, Portugal  \n2 iNOVA4Health, NOVA Medical School, Faculdade de Ciˆencias M´edicas, Universidade NOVA de Lisboa, Lisbon, Portugal  \n3 Instituto Portuguˆes de Oncologia de Lisboa Francisco Gentil (IPOLFG), Rua Prof Lima Basto, Lisbon, 1099-023, Portugal  \n4 Bioengineering Department, Instituto Superior T´ecnico, Instituto Superior T´ecnico, Lisbon, Portugal  \nKeywords  \nbreast carcinoma; membrane-targeted therapies; polycationic PURE dendrimers; triple-negative breast carcinoma  \nCorrespondence  \nV. D. B. Bonif´acio, iBB-Institute for Bioengineering and Biosciences, and Associate Laboratory i4HB-Institute for Health and Bioeconomy, Instituto Superior T´ecnico, Av Rovisco Pais 1, 1049-001 Lisboa, Portugal  \nTel: +351 21 841 7000  \nE-mail: [vasco.bonifacio@tecnico.ulisboa.pt](vasco.bonifacio@tecnico.ulisboa.pt)[ ](vasco.bonifacio@tecnico.ulisboa.pt)and  \nJ. Serpa, NOVA Medical School, Faculdade de Ciˆencias M´edicas, Universidade NOVA de Lisboa, Campo dos M´artires da P´atria,  \n130, 1169-056 Lisboa, Portugal  \nTel: +351 218 803 000  \nE-mail: [jacinta.serpa@nms.unl.pt](jacinta.serpa@nms.unl.pt)  \n(Received 17 March 2025, revised 15 July 2025, accepted 6 October 2025)  \ndoi:10.1002/2211-5463.70144  \nEdited by Ivana Novak  \nBreast carcinoma (BC) is the most common malignancy in women, with triple-negative breast cancer (TNBC) making up 10–20% of cases. TNBC has limited targeted therapies and poor survival due to late diagnosis and metastasis. Dendrimers are precise nanostructures with a three-dimensional globular architecture designed to target the negatively charged membranes of cancer cells. This study evaluated the anticancer potential of two novel core–shell polycationic polyurea (PURE) dendrimers, PUREG4-OEI48 and PUREG4-OCEI24, targeting BC cell membranes. Both dendrimers selectively interacted with TNBC cells, inducing apoptosis, necroptosis, and ferroptosis. In vivo, they reduced tumor volume in HCC1806 xenografts, with PUREG4-OEI48 showing no toxicity, while PUREG4-OCEI24 induced mild hepatic toxicity. These results suggest PURE dendrimers are promising TNBC treatments, with further modiﬁcations needed to enhance efﬁcacyand reduce toxicity.  \nAbbreviations  \nAST, aspartate aminotransferase; BC, breast carcinoma; BSA, bovine serum albumin; cDNA, complementary deoxyribonucleic acid; CTCF, corrected total cell ﬂuorescence; DMEM, Dulbecco’s Modiﬁed Eagle Medium; EC50, half-effective concentration; ELISA, Enzyme-linked Immunosorbent Assays; FBS, fetal bovine serum; FISH, ﬂuorescence in situ hybridization; HE, hematoxylin and eosin; LD, lipid droplet; NMR, nuclear magnetic resonance; OCT, optimal cutting temperature; PBS, phosphate-buffered saline; PE, phosphatidylethanolamine; PFA, paraformaldehyde; PI, propidium iodide; PS, phosphatidylserine; PURE, polyurea; RNA, ribonucleic acid; RT-qPCR, quantitative reverse transcription polymerase chain reaction; TNBC, triple-negative breast carcinoma.  \n944 FEBS Open Bio 16 (2026) 944–965 ª 2026 The Author(s) . FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nA. Cruz et al. Anticancer polycationic PURE dendrimers for TNBC  \nBreast carcinoma (BC) is the most prevalent malignancy among women globally, ranking ﬁrst in incidence among women and second overall [1] . Despite ad","cbCaidZ76sDL699k","https://ap.wps.com/l/cbCaidZ76sDL699k","pdf",4089207,22,"English","# Background\n## Breast carcinoma and TNBC characteristics\n## Limitations of targeted therapies and survival outcomes\n## Need for new TNBC treatments\n# Nanotechnology and dendrimers\n## Nanocarriers in cancer therapy\n## Rationale for dendrimer membrane targeting\n# Study focus\n## Design of core–shell polycationic PURE dendrimers\n## Cellular mechanisms and anticancer effects\n# In vivo evaluation\n## Tumor growth in HCC1806 xenografts\n## Toxicity assessment\n# Implications","[{\"question\":\"What TNBC problem does this research target?\",\"answer\":\"The research addresses limited targeted therapy options for TNBC and the poor survival associated with late diagnosis and metastasis.\"},{\"question\":\"Which two PURE dendrimers are investigated?\",\"answer\":\"The study evaluates PUREG4-OEI48 and PUREG4-OCEI24, both designed as core–shell polycationic polyurea dendrimers for TNBC membrane targeting.\"},{\"question\":\"What outcomes are observed in vitro and in vivo?\",\"answer\":\"In TNBC cells, the dendrimers induce apoptosis, necroptosis, and ferroptosis; in HCC1806 xenografts, they reduce tumor volume, with PUREG4-OEI48 showing no toxicity and PUREG4-OCEI24 causing mild hepatic toxicity.\"}]","Targeting TNBC - core-shell polycationic polyureadendrimers with inherent anticancer activity | PDF",1790109109,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d917f8926be0895369427d5dd72ed71.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80712c25c0ee884d6fca75809fc84a5e.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b263e9e955354b9c5c7a60e330713ffa.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/166f6b4daef75dfda4c37746bf534c7d.webp",980,1287]